CD142-positive synovial fibroblasts drive meniscus destruction in rheumatoid arthritis

Hao Sun1, Xiaobin Lin1, Fangzhou Liu1

  • 1Department of Joint Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Nature Communications
|July 28, 2025
PubMed

Insights

CD142+ fibroblasts in rheumatoid arthritis synovium drive meniscus destruction. Blocking ABCC4 with MK571 inhibits this damage, offering a new therapeutic target for knee joint preservation.

Area of Science:

  • Rheumatology
  • Cell Biology
  • Immunology

Background:

  • Rheumatoid arthritis (RA) primarily affects joints, with bone and cartilage damage being key features.
  • The role of the meniscus in RA pathogenesis has been under-explored.
  • Synovial fibroblasts are implicated in joint inflammation and destruction.

Purpose of the Study:

  • To investigate the role of CD142+ synovial fibroblasts in rheumatoid arthritis (RA) joint destruction.
  • To identify the mechanisms underlying CD142+ fibroblast-mediated meniscus damage.
  • To evaluate CD142+ fibroblasts as a prognostic indicator and therapeutic target in RA.

Main Methods:

  • Identification and characterization of CD142+ fibroblasts in normal, osteoarthritis, and rheumatoid arthritis synovium.
  • In vivo experiments injecting CD142+ fibroblasts into mouse knees.
  • Pharmacological inhibition of ABCC4 using MK571.
  • Analysis of cAMP/PKA signaling pathways.
  • Long-term follow-up of an RA patient cohort.

Main Results:

  • CD142+ fibroblasts are increased and located at the lining layer in RA synovium.
  • Injection of CD142+ fibroblasts into mouse knees caused significant meniscus destruction.
  • ABCC4 is highly expressed in CD142+ fibroblasts; its blockage attenuated meniscus destruction via cAMP/PKA signaling.
  • Enriched CD142+ fibroblasts in RA patients correlated with severe knee destruction and need for total knee arthroplasty.

Conclusions:

  • CD142+ synovial fibroblasts are a key driver of meniscus destruction in rheumatoid arthritis.
  • Targeting ABCC4 in CD142+ fibroblasts presents a potential therapeutic strategy to prevent RA-induced knee damage.
  • CD142+ fibroblasts serve as a valuable prognostic biomarker for severe joint destruction in RA.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
43
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K